FR1982M - Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles. - Google Patents

Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.

Info

Publication number
FR1982M
FR1982M FR904913A FR904913A FR1982M FR 1982 M FR1982 M FR 1982M FR 904913 A FR904913 A FR 904913A FR 904913 A FR904913 A FR 904913A FR 1982 M FR1982 M FR 1982M
Authority
FR
France
Prior art keywords
alkanamides
hydrazines
substituted
treatment
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR904913A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Application granted granted Critical
Publication of FR1982M publication Critical patent/FR1982M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
FR904913A 1961-07-27 1962-07-24 Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles. Active FR1982M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US127156A US3127420A (en) 1961-07-27 1961-07-27 N1-[(5-nitro-2-furyl)alkylidene]-n-substituted n-(n-substituted carbamoylalkyl) hydrazines

Publications (1)

Publication Number Publication Date
FR1982M true FR1982M (fr) 1963-08-26

Family

ID=22428599

Family Applications (1)

Application Number Title Priority Date Filing Date
FR904913A Active FR1982M (fr) 1961-07-27 1962-07-24 Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.

Country Status (7)

Country Link
US (1) US3127420A (fr)
BE (1) BE620732A (fr)
CH (1) CH410987A (fr)
DE (1) DE1518049A1 (fr)
ES (2) ES278308A1 (fr)
FR (1) FR1982M (fr)
GB (1) GB969101A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71111A1 (fr) * 1974-10-15 1976-08-19
US4942170A (en) * 1988-05-27 1990-07-17 The Rockefeller University 2-(substituted methylidene)-N-[3-[piperidin-1-yl]propyl]hydrazine carboximidamides useful as antiparasitics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2943019A (en) * 1958-06-24 1960-06-28 Norwich Pharma Co Anticoccidial composition and method of combatting coccidiosis
US3075877A (en) * 1960-12-13 1963-01-29 Norwich Pharma Co Anticoccidial compositions comprising 5-nitro-2-furaldehyde cyanoacetyl or dichloroacetyl-hydrazone

Also Published As

Publication number Publication date
GB969101A (en) 1964-09-09
DE1518049A1 (de) 1969-07-24
US3127420A (en) 1964-03-31
CH410987A (de) 1966-04-15
ES278308A1 (es) 1962-12-01
BE620732A (fr)
ES281232A1 (es) 1962-12-16

Similar Documents

Publication Publication Date Title
FR3290M (fr) Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.
FR2609M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR6247M (fr) Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
FR1982M (fr) Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.
FR126M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR1438M (fr) Nouveau médicament efficace dans le traitement de l'athérosclérose.
FR365M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR3244M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires d'origine rhumatismale, arthritique ou infectieuse.
FR1271648A (fr) Pince utilisable pour le traitement des cheveux
FR3875M (fr) Nouveau médicament convenant notamment au traitement des infections tuberculeuses.
FR1187M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires d'origine rhumatismale arthritique ou infectieuse.
FR1878M (fr) Nouveau polysaccharide, utilisable en thérapeutique, notamment pour le traitement des tumeurs solides.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l'hyperlipémie chronique ou post-prandiale.
FR1729M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1804M (fr) Nouveau médicament notamment pour le traitement des infections d'origine microbienne.
FR1731M (fr) Nouvel amino-pyrazole utilisable en thérapeutique, notamment comme médicament pour le traitement des affections inflammatoires.
FR1224M (fr) Traitement homéoflore des glandes sébacées.
FR1310580A (fr) Nouveaux agents de traitement, notamment pour le cuir, leur fabrication et leurs applications
FR33F (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1288M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie postprandiale ou aigue.